Earnings · China A-shares

Sichuan Biokin Pharmaceutical Co., Ltd. Class A (688506) earnings

Sichuan Biokin Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -42.55% year on year, -33.90% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +6.65% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-30
Period end
2026-09-30
Net profit YoY
-42.55%
Excl. one-offs YoY
-33.90%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+3.66%—
3 days+6.65%—
7 days+6.07%—
14 days+3.25%—

Report history

Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +1.44%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-31-¥704.92M-42.55%-33.90%+1.35%-1.71-11.66%+6.65%——
2026 interim report2026-08-27-¥1.64B-46.45%-43.58%+9.43%-3.97-28.92%-0.87%-14.12%-5.19%
2026 Q1 report2026-04-28-¥774.56M-45.75%-48.87%+40.25%-1.88-12.60%-4.14%-23.25%-22.62%
2025 annual report2026-04-28-¥1.05B-128.42%—-56.72%-2.61-24.55%-4.14%-23.25%-22.62%
2025 Q3 report2025-10-27-¥494.52M-112.16%—-63.52%-1.23-13.59%-2.43%+3.31%+3.54%
2025 interim report2025-08-20-¥1.12B-123.96%—-96.92%-2.79-33.60%+5.98%+19.90%+9.85%
2025 Q1 report2025-04-30-¥531.44M-110.62%—-98.77%-1.33-14.68%+0.64%+11.70%+8.53%
2024 annual report2025-03-29¥3.71B+575.02%+547.31%+936.31%9.25184.86%+4.22%+12.44%+14.00%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688506

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.